Literature DB >> 15114233

Dysphagia, obstructive sleep apnea, and difficult fiberoptic intubation secondary to diffuse idiopathic skeletal hyperostosis.

Bhiken Naik1, Emilio B Lobato, Cheri A Sulek.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15114233     DOI： 10.1097/00000542-200405000-00039

Source DB:  PubMed          Journal:  Anesthesiology        ISSN： 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  7 in total

Review 1.  Sleep apnea and cervical spine pathology.

Authors:  Adam Khan; Khoi D Than; Kevin S Chen; Anthony C Wang; Frank La Marca; Paul Park
Journal:  Eur Spine J       Date:  2013-10-09       Impact factor: 3.134

2.  Diffuse idiopathic skeletal hyperostosis: a rare cause of dysphagia and dysphonia.

Authors:  Thomas Peter Fox; Mihir Kumar Desai; Tom Cavenagh; Edward Mew
Journal:  BMJ Case Rep       Date:  2013-04-23

3.  Dysphagia due to diffuse idiopathic skeletal hyperostosis: an analysis of five cases.

Authors:  Stefano Masiero; Elena Padoan; Massimo Bazzi; Alessandro Ponzoni
Journal:  Rheumatol Int       Date:  2009-05-23       Impact factor: 2.631

Review 4.  Ossification of the cervical anterior longitudinal ligament is an underdiagnosed cause of difficult airway: a case report and review of the literature.

Authors:  Min Xu; Yue Liu; Jing Yang; Hao Liu; Chen Ding
Journal:  BMC Anesthesiol       Date:  2020-06-30       Impact factor: 2.217

5.  Diffuse idiopathic skeletal hyperostosis in ancient clergymen.

Authors:  J J Verlaan; F C Oner; G J R Maat
Journal:  Eur Spine J       Date:  2007-03-28       Impact factor: 3.134

6.  Refractory Obstructive Sleep Apnea in a Patient with Diffuse Idiopathic Skeletal Hyperostosis.

Authors:  Ara Darakjian; Ani B Darakjian; Edward T Chang; Macario Camacho
Journal:  Case Rep Otolaryngol       Date:  2016-11-09

7.  Morphological characteristics of diffuse idiopathic skeletal hyperostosis in the cervical spine.

Authors:  Jessica T Bakker; Jonneke S Kuperus; Hugo J Kuijf; F Cumhur Oner; Pim A de Jong; Jorrit-Jan Verlaan
Journal:  PLoS One       Date:  2017-11-20       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.